0001104659-23-098959.txt : 20230907 0001104659-23-098959.hdr.sgml : 20230907 20230907162608 ACCESSION NUMBER: 0001104659-23-098959 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230905 FILED AS OF DATE: 20230907 DATE AS OF CHANGE: 20230907 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Luptakova Katarina CENTRAL INDEX KEY: 0001991149 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40925 FILM NUMBER: 231242585 MAIL ADDRESS: STREET 1: C/O XILIO THERAPEUTICS, INC. STREET 2: 828 WINTER STREET CITY: WALTHAM STATE: MA ZIP: 02451 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Xilio Therapeutics, Inc. CENTRAL INDEX KEY: 0001840233 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 851623397 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 828 WINTER STREET CITY: WALTHAM STATE: MA ZIP: 02451 BUSINESS PHONE: 617-833-1027 MAIL ADDRESS: STREET 1: 828 WINTER STREET CITY: WALTHAM STATE: MA ZIP: 02451 4 1 tm2325621-2_4seq1.xml OWNERSHIP DOCUMENT X0508 4 2023-09-05 0 0001840233 Xilio Therapeutics, Inc. XLO 0001991149 Luptakova Katarina 828 WINTER STREET, SUITE 300 WALTHAM MA 02451 0 1 0 0 Chief Medical Officer 0 Stock Option (Right to Buy) 2.79 2023-09-05 4 A 0 106000 0 A 2033-09-04 Common Stock 106000 106000 D The option was granted on September 5, 2023 and will vest in equal monthly installments beginning on October 1, 2023 through September 1, 2027. /s/ Julia Walcott, Attorney-in-Fact 2023-09-07